Helius Medical Technologies (HSM) Stock Price, News & Analysis

Company Overview

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 930 shs
• Average Volume: 3,578 shs
• Market Capitalization: C$42.54 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: TSE:HSM
• CIK: N/A
• Web: heliusmedical.com
• Phone: 215-944-6100
• Fax: N/A
• Employees: 19
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.74
• Current Ratio: 4.20
• Quick Ratio: 3.58

Sales & Book Value

• Annual Sales: C$477 thousand
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 5.71
• Book Value: C$3.61 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 2,318,000
• Free Float: N/A
• Market Cap: C$42.54 million
• Optionable: Not Optionable
• Beta: N/A